Search

everythinglearnresearchcommunity

for

Search:↓

Comprehensive screening for infections is crucial before starting JAK inhibitors in alopecia areata patients.

Dithranol reduces inflammation in alopecia areata by lowering certain immune responses.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

Gamma/delta T cells help defend skin against heavy metals.

Early treatment of mixed connective tissue disease is crucial to prevent severe autoimmune conditions.

Certain immune cells in atopic dermatitis skin could be targeted for treatment.

Applying a DNA vaccine to skin with active hair growth boosts immune response and protection against anthrax in mice.

Vitiligo is now seen as a systemic disease with promising new treatments and may offer protection against some diseases.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

Removing certain hair follicle stem cells worsens skin reactions to allergens.

No single biomarker is reliable enough for diagnosing and assessing SLE.

Belatacept may be a promising treatment for alopecia areata.

Budesonide alone is less effective than standard treatment for autoimmune hepatitis.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Tocilizumab therapy may cause skin and hair conditions like halo naevi, vitiligo, and alopecia areata.

Ovalbumin–aluminum sensitization causes increased pain sensitivity and nerve changes in mice.

The patient's hair loss from alopecia totalis returned despite initial successful treatment.

Plaque-type herpetic folliculitis affects eccrine glands.

Staphylococcus simulans may cause dermatitis in African pygmy hedgehogs.

Early diagnosis and treatment by vets are crucial for managing rare but severe feline skin disorders.

Personalized treatment considering atopic status and cytokine profiles may help in managing pediatric alopecia areata.

Inactive stem cells in hair follicles and muscles can avoid detection by the immune system.

Nanoparticles can deliver vaccines through hair follicles, triggering immune responses and providing protection.

Immunotherapy for cancer caused a patient to develop a condition affecting hormone production, requiring ongoing hormone replacement therapy.

IL-17C is important in inflammatory skin diseases and could be a target for treatment.

Interface dermatitis is the most common skin change in drug-induced hypersensitivity syndrome.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

A woman had a severe skin reaction from the drug imiquimod, used for skin cancer, highlighting the need for awareness of rare but serious side effects.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.